Antibiotika in der Zahnmedizin. Michael Hülsmann
compared with experimental gingivitis in humans. Clin Oral Implants Res 2012;23:182–190.
8. Schwarz F, Mihatovic I, Golubovic V, Eick S, Iglhaut T, Becker J. Experimental peri-implant mucositis at different implant surfaces. J Clin Periodontol 2014;41:513-520.
9. Zitzmann NU, Berglundh T, Marinello CP, Lindhe J. Experimental peri-implant mucositis in man. J Clin Periodontol 2001;28:517–523.
10. Jepsen S, Berglundh T, Genco R, et al. Primary prevention of peri-implantitis: managing peri-implant mucositis. J Clin Periodontol 2015;42 Suppl 16:S152–157.
11. Schwarz F, Schmucker A, Becker J. Efficacy of alternative or adjunctive measures to conventional treatment of peri-implant mucositis and peri-implantitis: a systematic review and meta-analysis. Int J Implant Dent 2015;1:22.
12. Thoma DS, Naenni N, Figuero E et al. Effects of soft tissue augmentation procedures on peri-implant health or disease: A systematic review and meta-analysis. Clin Oral Implants Res 2018;29(Suppl 15):32–49.
13. Monje A, Blasi G. Significance of keratinized mucosa/gingiva on peri-implant and adjacent periodontal conditions in erratic maintenance compliers. J Periodontol 2019;90:445–453.
14. Roccuzzo M, Grasso G, Dalmasso P. Keratinized mucosa around implants in partially edentulous posterior mandible: 10-year results of a prospective comparative study. Clin Oral Implants Res 2016;27:491–496.
15. Lim HC, Wiedemeier DB, Hämmerle CHF, Thoma DS. The amount of keratinized mucosa may not influence peri-implant health in compliant patients: A retrospective 5-year analysis. J Clin Periodontol 2019;46:354–362.
16. Tabanella G, Nowzari H, Slots J. Clinical and microbiological determinants of ailing dental implants. Clin Implant Dent Relat Res 2009;11:24–36.
17. Heitz-Mayfield LJA, Salvi GE. Peri-implant mucositis. J Periodontol 2018;89 Suppl 1:S257-S266.
18. Ramanauskaite A, Becker K, Schwarz F. Clinical characteristics of peri-implant mucositis and peri-implantitis. Clin Oral Implants Res 2018;29:551–556.
19. Monje A, Vera M, Muñoz-Sanz A, Wang HL, Nart J. Suppuration as diagnostic criterium of peri-implantitis. J Periodontol. 2020 Jul 30. doi: 10.1002/JPER.20-0159. Epub ahead of print.
20. Fransson C, Wennström J, Berglundh T. Clinical characteristics at implants with a history of progressive bone loss. Clin Oral Implants Res 2008;19:142–147.
21. Lang NP, Berglundh T, Working Group 4 of Seventh European Workshop on P. Periimplant diseases: where are we now?--Consensus of the Seventh European Workshop on Periodontology. J Clin Periodontol 2011;38 Suppl 11:178–181.
22. Lang NP, Bosshardt DD, Lulic M. Do mucositis lesions around implants differ from gingivitis lesions around teeth? J Clin Periodontol 2011;38 Suppl 11:182–187.
23. Casado PL, Otazu IB, Balduino A, de Mello W, Barboza EP, Duarte ME. Identification of periodontal pathogens in healthy periimplant sites. Implant Dent 2011;20:226–235.
24. Ziebolz D, Schmalz G, Gollasch D, Eickholz P, Rinke S. Microbiological and aMMP-8 findings depending on peri-implant disease in patients undergoing supportive implant therapy. Diagn Microbiol Infect Dis 2017;88:47–52.
25. Al-Majid A, Alassiri S, Rathnayake N, Tervahartiala T, Gieselmann DR, Sorsa T. Matrix Metalloproteinase-8 as an Inflammatory and Prevention Biomarker in Periodontal and Peri-Implant Diseases. Int J Dent 2018;2018:7891323.
26. Koyanagi T, Sakamoto M, Takeuchi Y, Maruyama N, Ohkuma M, Izumi Y. Comprehensive microbiological findings in peri-implantitis and periodontitis. J Clin Periodontol 2013;40:218–226.
27. Lafaurie GI, Sabogal MA, Castillo DM, et al. Microbiome and Microbial Biofilm Profiles of Peri-Implantitis: A Systematic Review. J Periodontol 2017;88:1066–1089.
28. Perez-Chaparro PJ, Duarte PM, Shibli JA, et al. The Current Weight of Evidence of the Microbiologic Profile Associated With Peri-Implantitis: A Systematic Review. J Periodontol 2016;87:1295–1304.
29. Rakic M, Grusovin MG, Canullo L. The Microbiologic Profile Associated with Peri-Implantitis in Humans: A Systematic Review. Int J Oral Maxillofac Implants 2016;31:359–368.
30. Mombelli A, van Oosten MA, Schurch E, Jr., Land NP. The microbiota associated with successful or failing osseointegrated titanium implants. Oral Microbiol Immunol 1987;2:145–151.
31. Mombelli A, Decaillet F. The characteristics of biofilms in peri-implant disease. J Clin Periodontol 2011;38 Suppl 11:203–213.
32. Persson GR, Renvert S. Cluster of bacteria associated with peri-implantitis. Clin Implant Dent Relat Res 2014;16:783–793.
33. Schwarz F, Becker K, Rahn S, Hegewald A, Pfeffer K, Henrich B. Real-time PCR analysis of fungal organisms and bacterial species at peri-implantitis sites. Int J Implant Dent 2015;1:9.
34. Shibli JA, Melo L, Ferrari DS, Figueiredo LC, Faveri M, Feres M. Composition of supra- and subgingival biofilm of subjects with healthy and diseased implants. Clin Oral Implants Res 2008;19:975–982.
35. Hultin M, Gustafsson A, Hallstrom H, Johansson LA, Ekfeldt A, Klinge B. Microbiological findings and host response in patients with peri-implantitis. Clin Oral Implants Res 2002;13:349–358.
36. Leonhardt A, Renvert S, Dahlen G. Microbial findings at failing implants. Clin Oral Implants Res 1999;10:339–345.
37. Albertini M, López-Cerero L, O‘Sullivan MG et al. Assessment of periodontal and opportunistic flora in patients with peri-implantitis. Clin Oral Implants Res 2015;26:937–941.
38. Jankovic S, Aleksic Z, Dimitrijevic B et al. Prevalence of human cytomegalovirus and Epstein-Barr virus in subgingival plaque at peri-implantitis, mucositis and healthy sites. A pilot study. Int J Oral Maxillofac Surg 2011;40:271–276.
39. Antoci V, Jr., Adams CS, Parvizi J, Ducheyne P, Shapiro IM, Hickok NJ. Covalently attached vancomycin provides a nanoscale antibacterial surface. Clin Orthop Relat Res 2007;461:81–87.
40. Cosyn J, Van Aelst L, Collaert B, Persson GR, De Bruyn H. The peri-implant sulcus compared with internal implant and suprastructure components: a microbiological analysis. Clin Implant Dent Relat Res 2011;13:286–295.
41. Teughels W, Van Assche N, Sliepen I, Quirynen M. Effect of material characteristics and/or surface topography on biofilm development. Clin Oral Implants Res 2006;17 Suppl 2:68–81.
42. Kroger A, Hulsmann C, Fickl S, et al. The severity of human peri-implantitis lesions correlates with the level of submucosal microbial dysbiosis. J Clin Periodontol 2018;45:1498–1509.
43. Davies D. Understanding biofilm resistance to antibacterial agents. Nat Rev Drug Discov 2003;2:114–122.
44. Davey ME, O‘Toole G A. Microbial biofilms: from ecology to molecular genetics. Microbiol Mol Biol Rev 2000;64:847–867.
45. Dongari-Bagtzoglou A. Pathogenesis of mucosal biofilm infections: challenges and progress. Expert Rev Anti Infect Ther 2008;6:201–208.
46. Olson ME, Ceri H, Morck DW, Buret AG, Read RR. Biofilm bacteria: formation and comparative susceptibility to antibiotics. Can J Vet Res 2002;66:86–92.
47. Sanz M, Chapple IL, Working Group 4 of the VEWoP. Clinical research on peri-implant diseases: consensus report of Working Group 4. J Clin Periodontol 2012;39 Suppl 12:202–206.
48. Schwarz F, John G, Schmucker A, Sahm N, Becker J. Combined surgical therapy of advanced peri-implantitis evaluating two methods of surface decontamination: a 7-year follow-up observation. J Clin Periodontol 2017;44:337–342.
49. Schwarz F, Sahm N, Becker J. Impact of the outcome of guided bone regeneration in dehiscence-type defects on the long-term stability of peri-implant health: clinical observations at 4 years. Clin Oral Implants Res 2012;23:191–196.
50. Carcuac O, Derks J, Abrahamsson I, Wennstrom JL, Petzold M, Berglundh T. Surgical treatment of peri-implantitis: 3-year results from